How Arteriovenous Malformation Causes Hemorrhagic Stroke

Hemorrhagic strokes are caused by bleeding into the brain due to the rupture of a blood vessel. They are further divided into intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH). Hemorrhagic strokes are associated with high morbidity and mortality rates, and early diagnosis and treatment are crucial due to the rapid expansion of the hemorrhage, which can lead to a sudden deterioration of consciousness and neurological dysfunction. Arteriovenous malformations (AVMs) are abnormal tangles of blood vessels that disrupt the normal connections between arteries and veins. While AVMs can occur anywhere in the body, they are most commonly found in the spinal cord and brain. In the context of hemorrhagic strokes, AVMs can lead to intracerebral hemorrhage, which can cause stroke and brain damage. The risk of AVM-related hemorrhage is influenced by factors such as AVM size and location, with smaller AVMs and those located in certain areas of the brain being more prone to bleeding. Overall, AVMs are a rare cause of hemorrhagic strokes, but prompt diagnosis and appropriate treatment are essential to prevent severe complications and improve patient outcomes.

What is an arteriovenous malformation?

An arteriovenous malformation (AVM) is an abnormal tangle of blood vessels that disrupts the normal connection between arteries and veins. Typically, arteries carry oxygen-rich blood from the heart to the body's cells, organs, and tissues, while veins return blood with less oxygen to the lungs and heart. However, in an AVM, the absence of capillaries—small blood vessels that connect arteries and veins and deliver oxygenated blood to cells—allows blood to pass directly from arteries to veins, bypassing the tissue that requires this oxygenated blood. This can result in tissue damage and the death of nerve cells and other cell types. Over time, certain AVMs may gradually enlarge as the volume of blood flow increases.

AVMs most commonly develop in the spinal cord and brain but can form in other areas of the body. Brain AVMs, in particular, occur in less than 1% of the population and are more prevalent in males. They are usually congenital, meaning individuals are born with them, but they are typically not hereditary. AVMs can be discovered incidentally during treatment for unrelated disorders or at autopsy.

The symptoms of AVMs can vary from mild to severe and include seizures, headaches, pain, visual problems, muscle weakness, speech difficulties, movement issues, abnormal sensations, cognitive difficulties, dizziness, and loss of consciousness. The risk of severe hemorrhage is the most significant concern associated with AVMs. Although most bleeding episodes may go undetected due to their minor nature, fatal bleeding events can occur. Smaller AVMs and those with a history of bleeding are more prone to future bleeding episodes.

AVMs can be diagnosed using imaging technologies such as cerebral angiography, computed tomography (CT), magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), and transcranial Doppler (TCD) ultrasound. Treatment options include medication, surgery, endovascular embolization, and radiosurgery, depending on the type, location, symptoms, and the patient's overall health.

What are the symptoms of a brain AVM?

Arteriovenous malformations (AVMs) are abnormal tangles of blood vessels that cause problems with the connections between arteries and veins. They can develop in the brain or elsewhere in the body, but they are most common in the brain, brainstem, and spinal cord. AVMs can cause a range of symptoms, including:

• Seizures: These can be focal (involving a small part of the brain) or generalized (widespread) and may involve convulsions, loss of control over movement, or changes in consciousness.
• Headaches: These can vary in frequency, duration, and intensity and may be felt on one or both sides of the head.
• Pain: The location of the pain may not be specific to the malformation, but it can affect most of the head. Sudden, severe back pain and pain in the lower limbs may indicate a spinal AVM.
• Visual problems: AVMs near the optic nerve or occipital lobe may cause vision loss, inability to control eye movement, or swelling of the optic nerve.
• Muscle weakness or paralysis: This can occur in one part of the body. A spinal cord AVM can lead to degeneration of nerve fibers, causing widespread paralysis.
• Speech problems: AVMs in the brain or spinal cord can cause aphasia, or difficulty speaking or understanding language.
• Movement problems: AVMs in the brain stem and cerebellum can impair the ability to coordinate complex movements such as walking.
• Abnormal sensations: Some people with AVMs experience numbness, tingling, or spontaneous pain.
• Cognitive difficulties: These may include apraxia (difficulty carrying out tasks that require planning), memory problems, confusion, hallucinations, or dementia.
• Dizziness: Damage to the cerebellum and brain stem due to AVMs can result in dizziness.
• Loss of consciousness.
• Developmental differences: People with AVMs may exhibit subtle learning or behavioral differences during childhood or adolescence.

It is important to note that AVMs can be asymptomatic, and up to 15% of people with AVMs may not experience any symptoms. However, if left untreated, there is a 2-4% chance per year that an AVM will rupture and cause bleeding in the brain (hemorrhage), leading to stroke and brain damage.

What are the chances of a brain AVM bleeding?

Arteriovenous malformations (AVMs) occur when a group of blood vessels in the body forms incorrectly, bypassing normal tissue and directly diverting blood from the arteries to the veins. Brain AVMs occur in less than 1% of the population and are more common in males than in females.

The chance of a brain AVM bleeding is 1% to 3% per year. The risk of recurrent intracranial bleeding is slightly higher for a short time after the first bleed, and people aged 11 to 35 years old with an AVM are at a slightly higher risk of bleeding. The risk of death related to each bleed is 10% to 15%, and the chance of permanent brain damage is 20% to 30%.

AVMs can cause uncontrolled bleeding or hemorrhage, although this is rare, occurring in fewer than 4% of cases. Death as a direct result of an AVM occurs in about 1% of people with AVMs. The risk of severe hemorrhage is higher in smaller AVMs, and AVMs that have bled once are much more likely to bleed again, especially within the first year. Pregnancy also increases the likelihood of clinically significant hemorrhage due to increases in blood pressure and blood volume.

AVMs that have ruptured can cause a hemorrhagic stroke, which occurs when an artery bursts in the brain, causing localized bleeding in the surrounding tissue. Hemorrhagic strokes are life-threatening, with an estimated 5-year survival rate of about 26.7%. The prognosis depends on the location and severity of the bleeding and the amount of swelling that results.

What can happen if a brain AVM causes a bleed?

Arteriovenous malformations (AVMs) occur when a group of blood vessels in the brain forms incorrectly, bypassing normal brain tissue and directly diverting blood from the arteries to the veins. AVMs are abnormal tangles of blood vessels that cause problems with the connections between arteries and veins.

If a brain AVM causes a bleed, the risk of death is 10% to 15%, and the chance of permanent brain damage is 20% to 30%. Each time blood leaks into the brain, normal brain tissue is damaged, resulting in a loss of normal function that may be temporary or permanent. This can lead to difficulties with movement, speech, and vision, as well as seizures.

The chance of a brain AVM bleeding is 1% to 3% per year, and the risk of recurrent bleeding is slightly higher for a short time after the first bleed. People aged 11 to 35 years old with an AVM are at a slightly higher risk of bleeding.

AVMs can cause uncontrolled bleeding or hemorrhage. While fewer than 4% of AVMs hemorrhage, those that do can have severe, even fatal, effects. Death as a direct result of an AVM occurs in about 1% of people with AVMs.

AVMs can also reduce the amount of oxygen getting to the brain, causing a "steal" effect. This can put pressure on surrounding tissues and lead to hydrocephalus, or an accumulation of fluid within the brain.

The greatest potential danger posed by AVMs is hemorrhage. Massive, even fatal, bleeding episodes do occur. Smaller AVMs are more likely to bleed, and AVMs that have bled once are much more likely to bleed again. Impaired drainage by narrow or deeply located veins can also increase the likelihood of serious hemorrhage.

Large AVMs can press on surrounding brain structures and cause damage. They can constrict the flow of cerebrospinal fluid, which normally nourishes and protects the brain and spinal cord. This buildup of fluid can cause hydrocephalus and increase pressure on fragile neurological structures.

What is the best treatment for a dural fistula?

A dural arteriovenous fistula (DAVF) is an abnormal connection between an artery and a vein within the protective tissue (dura mater) that surrounds the brain and spinal cord. This can cause a range of symptoms, including nausea, vomiting, hearing a constant noise (pulsatile tinnitus), speech or language difficulties, trouble with balance and coordination, muscle weakness or numbness, pain in the face, arms or legs, and abnormal feelings or sensations. Some DAVFs do not cause symptoms and only require close monitoring. However, if a DAVF causes bleeding (hemorrhage), it can be life-threatening.

The best treatment for a DAVF is typically endovascular surgical blocking of the abnormal connections that have caused the fistula. This procedure, called endovascular embolization, involves inserting small tubes (catheters) inside the blood vessel with X-ray guidance and blocking off the abnormal connections using a substance such as glue or coils. This treatment method can permanently cure the fistula by blocking the abnormal passageway.

In some cases, microsurgical resection may be necessary, where a surgeon completely removes the abnormal vessels. This approach is typically used when the risk of hemorrhage is high or when the catheter cannot reach the DAVF. Stereotactic radiosurgery, a form of radiation therapy, may also be used in specific cases to block off the fistula connection using focused beams of radiation.

The choice of treatment depends on several factors, including the anatomy of the DAVF, the patient's general health, symptoms, and risk of bleeding or other complications.

Frequently asked questions